Product Overview
Dermorphin D-Amino-Acid Opioid Research Heptapeptide
High-quality Dermorphin d-amino-acid opioid research heptapeptide for specialty peptide apis and laboratory analytical research
Dermorphin is supplied as a d-amino-acid opioid research heptapeptide for qualified laboratory research in sequence-defined peptide characterisation, receptor or membrane-interaction assays, analytical method development and raw-material quality control. Available specifications: 5 mg × 10 vials. For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Synonym(s): Dermorphin; Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2
Packaging & Availability
Pricing is supplied on request. Select one or more pack sizes to add them to your quote cart.
| Select | SKU | Pack Size | Availability | Price |
|---|---|---|---|---|
| DR5 | 5mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request |
Product Overview
Dermorphin is supplied as a d-amino-acid opioid research heptapeptide for qualified research organisations, analytical laboratories and product-development teams. It is positioned for sequence-defined peptide characterisation, receptor or membrane-interaction assays, analytical method development and raw-material quality control. The final website specification must match the released batch COA and SDS.
Key Features
- Product type: D-Amino-Acid Opioid Research Heptapeptide
- Available specifications: 5 mg × 10 vials
- Purity / quality: Research grade; enter the exact assay or HPLC purity shown on the batch COA
- Appearance: White to off-white lyophilized powder; confirm against the batch COA
- Quality documentation: batch COA, HPLC or potency assay, MS where applicable, SDS and specification sheet
- Bulk supply and custom labelling are subject to technical, quality and compliance review
Research Applications
Typical non-clinical research use includes sequence-defined peptide characterisation, receptor or membrane-interaction assays, analytical method development and raw-material quality control, chromatographic method development, mass-spectrometric or potency confirmation, stability assessment, formulation compatibility and raw-material quality control. The purchaser is responsible for validating suitability in the intended protocol.
Quality & Supply
Batch-specific documentation is available according to the selected grade and order. State the required content, quantity, assay/purity, destination country, packaging format and required documents when requesting a quotation.
For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Frequently Asked Questions
What is Dermorphin?
Dermorphin is supplied as a d-amino-acid opioid research heptapeptide for qualified laboratory research.
What specifications are available?
Current catalogue specifications are 5 mg × 10 vials. Final availability must be confirmed when requesting a quotation.
What purity or quality is supplied?
Research grade; enter the exact assay or HPLC purity shown on the batch COA. The released batch COA is the controlling quality record.
Which quality documents are available?
Batch COA, HPLC or potency-assay results, MS where applicable, SDS and a specification sheet may be available depending on the product and batch.
How should Dermorphin be stored?
Store sealed at −20°C, protected from light and moisture. Follow batch-specific stability instructions after reconstitution and avoid repeated freeze–thaw cycles.
Is Dermorphin intended for human use?
No. It is supplied for laboratory research only and is not intended for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Product Properties
| Product Name | Dermorphin |
|---|---|
| Product Type | D-Amino-Acid Opioid Research Heptapeptide |
| Main Category | Peptide APIs |
| Subcategory | Specialty Peptide APIs |
| Available Specifications | 5 mg × 10 vials |
| Purity / Quality | Research grade; enter the exact assay or HPLC purity shown on the batch COA |
| Appearance | White to off-white lyophilized powder; confirm against the batch COA |
| Storage | Store sealed at −20°C, protected from light and moisture. Follow batch-specific stability instructions after reconstitution and avoid repeated freeze–thaw cycles. |
| Quality Documents | Batch COA; HPLC or potency assay; MS where applicable; SDS; specification sheet |
Analytical & Research Scope
Dermorphin may be evaluated in sequence-defined peptide characterisation, receptor or membrane-interaction assays, analytical method development and raw-material quality control. Final method suitability, acceptance criteria and regulatory classification must be established by the purchaser.
Ordering Information
Specify the required content, quantity, assay/purity, packaging format, destination and required documents when requesting a quotation.
For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
- Read the batch-specific Safety Data Sheet and product specification before handling.
- Use suitable laboratory gloves, protective clothing and eye protection.
- Avoid inhalation, ingestion and direct contact with skin or eyes.
- Use only in a controlled laboratory environment with appropriate engineering controls.
- Store sealed at −20°C, protected from light and moisture. Follow batch-specific stability instructions after reconstitution and avoid repeated freeze–thaw cycles.
- Dispose of unused material, solutions and packaging according to institutional and local requirements.
No clinical dosing, treatment or consumer-use information is provided.
Quality & Documentation
Safety Data Sheet (SDS), Certificate of Analysis (COA) and specification documents can be supplied with your quotation.